Connor, Clark & Lunn Investment Management (CC&L)’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,354
| Closed | -$364K | – | 1477 |
|
|
2024
Q4 | $364K | Buy |
65,354
+38,031
| +139% | +$212K | ﹤0.01% | 1223 |
|
|
2024
Q3 | $295K | Buy |
+27,323
| New | +$295K | ﹤0.01% | 1244 |
|
|
2023
Q3 | – | Sell |
-21,824
| Closed | -$394K | – | 1417 |
|
|
2023
Q2 | $394K | Sell |
21,824
-26,975
| -55% | -$487K | ﹤0.01% | 1047 |
|
|
2023
Q1 | $839K | Buy |
48,799
+601
| +1% | +$10.3K | ﹤0.01% | 760 |
|
|
2022
Q4 | $1.07M | Buy |
+48,198
| New | +$1.07M | 0.01% | 685 |
|